On August 6, 2004, my mother’s life changed forever—not just because she had a child, but because that child, me, was diagnosed with severe hemophilia B. This rare bleeding disorder prevents my blood ...

The patient was prescribed 20 mg of ruxolitinib twice a day plus 0.6 g of flumatinib once a day. Treatment with flumatinib plus ruxolitinib seems safe and effective in patients with primary ...

Regarding the pediatric population, mold-active antifungal prophylaxis is recommended for pediatric patients at high risk of IFD, including a subgroup of children with ALL. Regarding the pediatric ...

When I was first diagnosed with immune thrombocytopenia (ITP), it was all scary and new. I had just spent a week in the hospital and was being sent home with orders to see a hematologist in my area ...

I’m writing this from Deck 14 on the cruise ship Celebrity Beyond. Cruising isn’t new to me, but it’s often a challenge because of my multiple sclerosis (MS) mobility problems. This trip hasn’t been ...

There’s something about not being able to walk that makes people uneasy. For most of my adult life, I haven’t given much thought to my scooter whenever I’m out in public. I’m just so used to it that I ...

The objective response rate was 36.1% for nivolumab plus ipilimumab versus 13.2% for the control arm. Approval was based on findings from the CHECKMATE-9DW trial (NCT04039607), a randomized, ...